{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:58:11Z","timestamp":1723251491002},"reference-count":26,"publisher":"CMA Impact Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["cmajo"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.9778\/cmajo.20210173","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T11:25:50Z","timestamp":1639481150000},"page":"E1181-E1186","source":"Crossref","is-referenced-by-count":1,"title":["The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis"],"prefix":"10.9778","volume":"9","author":[{"given":"Charlotte G.","family":"Boone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Juurlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teagan Rolf","family":"von den Baumen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie A.","family":"Kitchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia C.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Tadrous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"382","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"2021121403251506000_9.4.E1181.1","doi-asserted-by":"publisher","DOI":"10.24095\/hpcdp.38.6.02"},{"key":"2021121403251506000_9.4.E1181.2","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20140027"},{"key":"2021121403251506000_9.4.E1181.3","unstructured":"(2015) Position statement: sale of exempted codeine preparations (Nova Scotia College of Pharmacists, Halifax)."},{"key":"2021121403251506000_9.4.E1181.4","doi-asserted-by":"crossref","unstructured":"Sproule B (2015) Prescription monitoring programs in Canada: best practice and program review (Canadian Centre on Substance Abuse, Ottawa).","DOI":"10.1016\/j.drugalcdep.2015.07.565"},{"key":"2021121403251506000_9.4.E1181.5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/7854_2015_422","article-title":"Over-the-counter codeine-from therapeutic use to dependence, and the grey areas in between","volume":"34","author":"Nielsen","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"2021121403251506000_9.4.E1181.6","doi-asserted-by":"crossref","first-page":"30049","DOI":"10.18433\/jpps30049","article-title":"Purchasing over the counter (OTC) medicinal products containing codeine: easy access, advertising, misuse and perceptions of medicinal risk","volume":"21","author":"Wells","year":"2018","journal-title":"J Pharm Pharm Sci"},{"key":"2021121403251506000_9.4.E1181.7","first-page":"29","article-title":"Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand","volume":"124","author":"McAvoy","year":"2011","journal-title":"N Z Med J"},{"key":"2021121403251506000_9.4.E1181.8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/dar.12224","article-title":"Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series","volume":"34","author":"Nielsen","year":"2015","journal-title":"Drug Alcohol Rev"},{"key":"2021121403251506000_9.4.E1181.9","unstructured":"(Jan 16, 2020) Narcotic Control Regulations (C.R.C., c. 1041) (Government of Canada, Ottawa) amended 2019 Dec 9. Available: https:\/\/laws-lois.justice.gc.ca\/eng\/Regulations\/C.R.C.,_c._1041\/index.html . accessed 2020 May 20."},{"key":"2021121403251506000_9.4.E1181.10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/dar.12059","article-title":"A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs","volume":"32","author":"Arora","year":"2013","journal-title":"Drug Alcohol Rev"},{"key":"2021121403251506000_9.4.E1181.11","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2014.904744"},{"key":"2021121403251506000_9.4.E1181.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.02.020"},{"key":"2021121403251506000_9.4.E1181.13","unstructured":"Drug scheduling in Canada: general overview (National Association of Pharmacy Regulatory Authorities (NAPRA), Ottawa) Available: https:\/\/napra.ca\/drug-scheduling-canada-general-overview . accessed 2020 July 14."},{"key":"2021121403251506000_9.4.E1181.14","unstructured":"Zlomislic D Yang J (Jan 13, 2016) Toronto Star, Manitoba sets new rule banning non-prescription codeine. updated 2016 Feb 1. Available: https:\/\/www.thestar.com\/life\/health_wellness\/2016\/01\/13\/manitoba-sets-new-rule-limiting-codeine.html . accessed 2020 Aug. 23."},{"key":"2021121403251506000_9.4.E1181.15","unstructured":"Samoila K (2018) Exempted codeine products (ECPs): proposed regulatory bylaw amendments: stakeholder consultation [memorandum] (Saskatchewan College of Pharmacy Professionals (SCPP), Regina (SK))."},{"key":"2021121403251506000_9.4.E1181.16","unstructured":"(2017) Canada Gazette, Part I, Controlled Drug and Substances Act: notice to interested parties \u2013 Non-prescription availability of low-dose codeine products (Government of Canada, Ottawa) Government Notices, Available: https:\/\/gazette.gc.ca\/rp-pr\/p1\/2017\/2017-09-09\/html\/notice-avis-eng.html , 151, 136, accessed 2020 Aug. 23."},{"key":"2021121403251506000_9.4.E1181.17","unstructured":"CMA submission on non-prescription availability of low-dose codeine products (Canadian Medical Association (CMA), Ottawa) Available: https:\/\/policybase.cma.ca\/documents\/BriefPDF\/BR2018-04.pdf . accessed 2020 Sept. 10."},{"key":"2021121403251506000_9.4.E1181.18","unstructured":"Krawchenko I (2017) Canadian Pharmacists Association submission re: non-prescription availability of low-dose codeine products (Canadian Pharmacists Association, Ottawa) Available: https:\/\/www.pharmacists.ca\/cpha-ca\/assets\/File\/cpha-on-the-issues\/CPhA%20Submission%20to%20HC_Codeine%2011_08_17.pdf . accessed 2020 Sept. 10."},{"key":"2021121403251506000_9.4.E1181.19","unstructured":"Forward Regulatory Plan 2021\u20132023 proposed regulations amending the narcotic control regulations under the Controlled Drugs and Substances Act to make all products containing codeine available by prescription only while ensuring access to these medications (Government of Canada, Ottawa) modified 2021 Apr. 1. Available: https:\/\/www.canada.ca\/en\/health-canada\/corporate\/about-health-canada\/legislation-guidelines\/acts-regulations\/forward-regulatory-plan\/plan\/codeine-prescription.html . accessed 2021 Sept. 2."},{"key":"2021121403251506000_9.4.E1181.20","unstructured":"Annual demographic estimates: Canada, provinces and territories (Statistics Canada, Ottawa) Cat. no. 91-215-X. Available: https:\/\/www150.statcan.gc.ca\/n1\/en\/catalogue\/91-215-X . accessed 2020 Mar. 7."},{"key":"2021121403251506000_9.4.E1181.21","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20170104"},{"key":"2021121403251506000_9.4.E1181.22","unstructured":"Blackwell T (Sept 11, 2017) National Post [Toronto], Ottawa proposes making OTC codeine pills prescription-only after years of pressure. Available: https:\/\/nationalpost.com\/health\/ottawa-proposes-making-otc-codeine-pills-prescription-only-after-years-of-pressure#:~:text=the%20industrialized%20world.-,Ottawa%20proposes%20making%20OTC%20codeine%20pills%20prescription%2Donly%20after%20years,with%20acetaminophen%20or%20other%20painkillers . accessed 2021 Apr. 28."},{"key":"2021121403251506000_9.4.E1181.23","unstructured":"Health Canada consultation: OTC codeine products (2017) The Island Capsule (Prince Edward Island College of Pharmacy, Charlottetown) Available: https:\/\/pepharmacists.ca\/wp-content\/uploads\/2020\/09\/Island-Capsule-Edition-3-Volume-30.pdf . accessed 2021 Mar. 22."},{"key":"2021121403251506000_9.4.E1181.24","doi-asserted-by":"publisher","DOI":"10.1111\/add.14798"},{"key":"2021121403251506000_9.4.E1181.25","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50552"},{"key":"2021121403251506000_9.4.E1181.26","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv373"}],"container-title":["CMAJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9778\/cmajo.20210173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T11:26:33Z","timestamp":1639481193000},"score":1,"resource":{"primary":{"URL":"http:\/\/cmajopen.ca\/lookup\/doi\/10.9778\/cmajo.20210173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12,14]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.9778\/cmajo.20210173"],"URL":"https:\/\/doi.org\/10.9778\/cmajo.20210173","relation":{},"ISSN":["2291-0026"],"issn-type":[{"value":"2291-0026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}